We have observed
16 EP applications
Rebecca Marie Tollervey
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF
RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS
TREATMENT OF B CELL LYMPHOMAS
Methods for genetic analysis
CARRIERS FOR IMPROVED DRUG DELIVERY
PURIFICATION OF VIRUS LIKE PARTICLES
EFFICIENT COMPARISON OF POLYNUCLEOTIDE SEQUENCES
Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method
Methods useful in nucleic acid sequencing protocols
ELECTRIC CURTAIN-CLOSING DEVICE AND CURTAIN-CLOSING METHOD USING SAME
TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE
HAND, FOOT, AND MOUTH VACCINES AND METHODS OF MANUFACTURE AND USE THEREOF
THERAPEUTIC VITAMIN D CONJUGATES
METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION
ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF